The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Designing CD4 immunoadhesins for AIDS therapy
Open accessAbstract
A newly-constructed antibody-like molecule containing the gp!20-binding domain of the receptor for human immunodeficiency virus blocks HIV-1 infection of T cells and monocytes. Its long plasma half-life, other antibody-like properties, and potential to block all HIV isolates, make it a good candidate for therapeutic use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., & Axel, R. (1986) · Cell · doi:10.1016/0092-8674(86)90590-8 · Cited by 2,002
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Self-citationBinding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 Molecule
McDougal, J. S., Kennedy, M. S., Sligh, J. M., Cort, S. P., Mawle, A., & Nicholson, J. K. A. (1986) · Science · doi:10.1126/science.3001934 · Cited by 989
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., & Capon, D. J. (1987) · Cell · doi:10.1016/0092-8674(87)90524-1 · Cited by 828
Self-citationInteraction between CD4 and class II MHC molecules mediates cell adhesion
Doyle, C., & Strominger, J. L. (1987) · Nature · doi:10.1038/330256a0 · Cited by 821
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
Sodroski, J., Goh, W. C., Rosen, C., Campbell, K., & Haseltine, W. A. (1986) · Nature · doi:10.1038/322470a0 · Cited by 798
Cited by
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
de Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., Darbonne, W. C., Henzel, W. J., Wong, S. C., Kuang, W.-J., et al. (1994) · Nature · doi:10.1038/369533a0 · Cited by 1,263
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Antibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Self-citationFoxall, C., Watson, Sr., Dowbenko, D., Fennie, C., Lasky, L., Kiso, M., Hasegawa, A., Asa, D., & Brandley, B. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.4.895 · Cited by 687
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., & Schwall, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624
Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Fc‐fusion proteins: new developments and future perspectives
Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201379 · Cited by 476
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
Strohl, W. R. (2015) · BioDrugs · doi:10.1007/s40259-015-0133-6 · Cited by 461
A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding
Sako, D., Comess, K. M., Barone, K. M., Camphausen, R. T., Cumming, D. A., & Shaw, G. D. (1995) · Cell · doi:10.1016/0092-8674(95)90173-6 · Cited by 434
Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides
Romeo, C., & Seed, B. (1991) · Cell · doi:10.1016/0092-8674(91)90327-u · Cited by 396
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Self-citationYang, W.-P., Green, K., Pinz-Sweeney, S., Briones, A. T., Burton, D. R., & Barbas III, C. F. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0626 · Cited by 333
Kim, J., & Somorjai, G. A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja028987n · Cited by 325
Peppel, K., Crawford, D., & Beutler, B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1483 · Cited by 321
Modern Surface Science and Surface Technologies: An Introduction
Somorjai, G. A. (1996) · Chemical Reviews · doi:10.1021/cr950234e · Cited by 310
Moore, J. P., & Sodroski, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1863-1872.1996 · Cited by 304
Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor.
Imai, Y., Singer, M. S., Fennie, C., Lasky, L. A., & Rosen, S. D. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.5.1213 · Cited by 300
Moore, J. P., McKeating, J. A., Huang, Y. X., Ashkenazi, A., & Ho, D. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.235-243.1992 · Cited by 284
Ehlers, M. R. W., & Riordan, J. F. (1991) · Biochemistry · doi:10.1021/bi00106a001 · Cited by 281
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Rath, T., Baker, K., Dumont, J. A., Peters, R. T., Jiang, H., Qiao, S.-W., Lencer, W. I., Pierce, G. F., & Blumberg, R. S. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.834293 · Cited by 281
Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor–IgG chimaera
Watson, S. R., Fennie, C., & Lasky, L. A. (1991) · Nature · doi:10.1038/349164a0 · Cited by 280
Current progress in innovative engineered antibodies
Strohl, W. R. (2018) · Protein & Cell · doi:10.1007/s13238-017-0457-8 · Cited by 279
Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamow, S. M., Figari, I. S., Pennica, D., Goeddel, D. V., Palladino, M. A., & Smith, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10535 · Cited by 275
Self-citationHuman Antibody Effector Function
Burton, D. R., & Woof, J. M. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60486-1 · Cited by 265
Winslow, J. W., Moran, P., Valverde, J., Shih, A., Yuan, J. O., Wong, S. C., Tsai, S. P., Goddard, A., Henzel, W. J., Hefti, F., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90335-6 · Cited by 259
Soluble N-Cadherin Overexpression Reduces Features of Atherosclerotic Plaque Instability
Lyon, C. A., Johnson, J. L., Williams, H., Sala-Newby, G. B., & George, S. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178087 · Cited by 51
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
Czajkowsky, D. M., Andersen, J. T., Fuchs, A., Wilson, T. J., Mekhaiel, D., Colonna, M., He, J., Shao, Z., Mitchell, D. A., Wu, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09526 · Cited by 38
Metadata
- Authors
- Capon, D. J., Chamow, S. M., Mordenti, J., Marsters, S. A., Gregory, T., Mitsuya, H., Byrn, R. A., Lucas, C., Wurm, F. M., Groopman, J. E., Broder, S., & Smith, D. H.
- Venue
- Nature
- Published
- 1989-02
- Volume
- 337
- Issue
- 6207
- Pages
- 525-531
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2074969682
- Cited by
- 615
- References
- 44
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.